These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37844798)

  • 21. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study.
    Paldus B; Lee MH; Jones HM; McAuley SA; Horsburgh JC; Roem KL; Ward GM; MacIsaac RJ; Cohen N; Colman PG; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Jan; 21(1):56-58. PubMed ID: 30620641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated Insulin Delivery Around Exercise in Adults with Type 1 Diabetes: A Pilot Randomized Controlled Study.
    McCarthy OM; Christensen MB; Kristensen KB; Schmidt S; Ranjan AG; Bain SC; Bracken RM; Nørgaard K
    Diabetes Technol Ther; 2023 Jul; 25(7):476-484. PubMed ID: 37053529
    [No Abstract]   [Full Text] [Related]  

  • 23. Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System.
    Shalit R; Minsky N; Laron-Hirsh M; Cohen O; Kurtz N; Roy A; Grosman B; Benedetti A; Tirosh A
    Diabetes Technol Ther; 2023 Sep; 25(9):579-588. PubMed ID: 37335759
    [No Abstract]   [Full Text] [Related]  

  • 24. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
    Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
    Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies.
    Christiansen M; Bartee A; Lalonde A; Jones RE; Katz M; Wolpert H; Brazg R
    Diabetes Technol Ther; 2021 Mar; 23(3):187-194. PubMed ID: 32940537
    [No Abstract]   [Full Text] [Related]  

  • 26. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
    Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
    J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
    Sala-Mira I; Garcia P; Díez JL; Bondia J
    Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes.
    Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A; Gil-Poch E; Martín-Romo I; Arroyo-Díez FJ
    Diabetes Technol Ther; 2021 Sep; 23(9):609-615. PubMed ID: 33784187
    [No Abstract]   [Full Text] [Related]  

  • 30. Study protocol: a randomised controlled proof-of-concept real-world study - does maximising time in range using hybrid closed loop insulin delivery and a low carbohydrate diet restore the glucagon response to hypoglycaemia in adults with type 1 diabetes?
    Baxter F; Baillie N; Forbes S
    BMJ Open; 2022 Dec; 12(12):e054958. PubMed ID: 36600427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
    Carlson AL; Sherr JL; Shulman DI; Garg SK; Pop-Busui R; Bode BW; Lilenquist DR; Brazg RL; Kaiserman KB; Kipnes MS; Thrasher JR; Reed JHC; Slover RH; Philis-Tsimikas A; Christiansen M; Grosman B; Roy A; Vella M; Jonkers RAM; Chen X; Shin J; Cordero TL; Lee SW; Rhinehart AS; Vigersky RA
    Diabetes Technol Ther; 2022 Mar; 24(3):178-189. PubMed ID: 34694909
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies.
    Annuzzi G; Triggiani R; De Angelis R; Rainone C; Corrado A; Scidà G; Lupoli R; Bozzetto L
    J Diabetes Complications; 2024 Feb; 38(2):108689. PubMed ID: 38244326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-home use of a hybrid closed loop achieves time-in-range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial.
    von dem Berge T; Remus K; Biester S; Reschke F; Klusmeier B; Adolph K; Holtdirk A; Thomas A; Kordonouri O; Danne T; Biester T
    Diabetes Obes Metab; 2022 Jul; 24(7):1319-1327. PubMed ID: 35373894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time Spent in Hypoglycemia According to Age and Time of Day: Observations During Closed-Loop Insulin Delivery.
    Alwan H; Ware J; Boughton CK; Wilinska ME; Allen JM; Lakshman R; Nwokolo M; Hartnell S; Bally L; de Beaufort C; Besser REJ; Campbell FM; Davis N; Denvir L; Evans ML; Fröhlich-Reiterer E; Ghatak A; Hofer SE; Kapellen TM; Leelarathna L; Mader JK; Narendran P; Rami-Mehrar B; Tauschmann M; Thabit H; Thankamony A; Hovorka R
    Diabetes Technol Ther; 2023 Jul; 25(7):485-491. PubMed ID: 37229591
    [No Abstract]   [Full Text] [Related]  

  • 36. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes.
    Bassi M; Teliti M; Lezzi M; Iosca A; Strati MF; Carmisciano L; d'Annunzio G; Minuto N; Maggi D
    Front Endocrinol (Lausanne); 2021; 12():802419. PubMed ID: 35116007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial.
    Reznik Y; Carvalho M; Fendri S; Prevost G; Chaillous L; Riveline JP; Hanaire H; Dubois S; Houéto P; Pasche H; Mianowska B; Renard E
    Diabetes Obes Metab; 2024 Feb; 26(2):622-630. PubMed ID: 37921083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.